Works matching IS 13524585 AND DT 2017 AND VI 23 AND IP 13

Results: 23

Methylphenidate is likely less effective than placebo for improving imbalance, walking, and fatigue in people with multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1799, doi. 10.1177/1352458517692421

By:

Cameron, Michelle H.;
McMillan, Garnett

Publication type:

Article

Clinical commentary on "Paroxysmal kinesigenic dyskinesialike phenotype in multiple sclerosis" and "Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients".

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1797, doi. 10.1177/1352458517702555

By:

Pareés, Isabel

Publication type:

Article

Paroxysmal kinesigenic dyskinesia-like phenotype in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1795, doi. 10.1177/1352458517702535

By:

Pop, Roxana;
Kipfer, Stefan

Publication type:

Article

Secondary paroxysmal dyskinesia in multiple sclerosis: Clinical-radiological features and treatment. Case report of seven patients.

Published in:

2017

By:

Ciampi, Ethel;
Uribe-San-Martín, Reinaldo;
Godoy-Santín, Jaime;
Cruz, Juan Pablo;
Cárcamo-Rodríguez, Claudia;
Juri, Carlos

Publication type:

Case Study

Protective personality traits: High openness and low neuroticism linked to better memory in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1786, doi. 10.1177/1352458516685417

By:

Leavitt, Victoria M.;
Buyukturkoglu, Korhan;
Inglese, Matilde;
Sumowski, James F.

Publication type:

Article

Similar familial risk in multiple sclerosis subgroups.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1782, doi. 10.1177/1352458516684214

By:

Jie Song;
Karrenbauer, Virginija;
Manouchehrinia, Ali;
Almqvist, Catarina;
Hillert, Jan;
Westerlind, Helga

Publication type:

Article

Smokers with MS have greater decrements in quality of life and disability than non-smokers.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1772, doi. 10.1177/1352458516685169

By:

Briggs, Farren B. S.;
Gunzler, Douglas D.;
Ontaneda, Daniel;
Marrie, Ruth Ann

Publication type:

Article

Impairment of decision-making in multiple sclerosis: A neuroeconomic approach.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1762, doi. 10.1177/1352458516682103

By:

Sepúlveda, Maria;
Fernández-Diez, Begoña;
Martínez-Lapiscina, Elena H.;
Llufriu, Sara;
Sola-Valls, Nuria;
Zubizarreta, Irati;
Blanco, Yolanda;
Saiz, Albert;
Levy, Dino;
Glimcher, Paul;
Villoslada, Pablo

Publication type:

Article

Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1748, doi. 10.1177/1352458516685416

By:

Jin Myoung Seok;
Hye-Jin Cho;
Suk-Won Ahn;
Eun Bin Cho;
Min Su Park;
In-Soo Joo;
Ha Young Shin;
Sun-Young Kim;
Byung-Jo Kim;
Jong Kuk Kim;
Joong-Yang Cho;
So-Young Huh;
Ohyun Kwon;
Kwang-Ho Lee;
Byoung Joon Kim;
Ju-Hong Min

Publication type:

Article

No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1736, doi. 10.1177/1352458516683266

By:

Kappos, Ludwig;
Havrdova, Eva;
Giovannoni, Gavin;
Khatri, Bhupendra O.;
Gauthier, Susan A.;
Greenberg, Steven J.;
Xiaojun You;
Ping Wang;
Giannattasio, Giorgio

Publication type:

Article

Defining active progressive multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1727, doi. 10.1177/1352458517726592

By:

Sellebjerg, Finn;
Börnsen, Lars;
Ammitzbøll, Cecilie;
Nielsen, Jørgen Erik;
Vinther-Jensen, Tua;
Hjermind, Lena Elisabeth;
von Essen, Marina;
Ratzer, Rikke Lenhard;
Sørensen, Per Soelberg;
Christensen, Jeppe Romme

Publication type:

Article

miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1716, doi. 10.1177/1352458516684213

By:

Quintana, Ester;
Ortega, Francisco José;
Robles-Cedeño, René;
Villar, María Luisa;
Buxó, Maria;
Mercader, Josep Maria;
Alvarez-Cermeño, José Carlos;
Pueyo, Neus;
Perkal, Héctor;
Fernández-Real, José Manuel;
Ramió-Torrentà, Lluís

Publication type:

Article

Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1707, doi. 10.1177/1352458516684022

By:

Cristofanilli, Massimiliano;
Gratch, Daniel;
Pagano, Benjamin;
McDermott, Kelsey;
Huang, Jessie;
Jian, Jeffrey;
Bates, Deneb;
Sadiq, Saud A.

Publication type:

Article

Genetic susceptibility to multiple sclerosis: Brain structure and cognitive function in the general population.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1697, doi. 10.1177/1352458516682104

By:

Ikram, Mohammad Arfan;
Vernooij, Meike W.;
Roshchupkin, Gennady V.;
Hofman, Albert;
van Duijn, Cornelia M.;
Uitterlinden, André G.;
Niessen, Wiro J.;
Hintzen, Rogier Q.;
Adams, Hieab H. H.

Publication type:

Article

Operationalising cognitive fatigability in multiple sclerosis: A Gordian knot that can be cut?

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1682, doi. 10.1177/1352458516681862

By:

Harrison, Anthony Mark;
das Nair, Roshan;
Moss-Morris, Rona

Publication type:

Article

Physician-assisted death should be available to people with MS - Commentary.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1681, doi. 10.1177/1352458517730133

By:

Coles, Alasdair

Publication type:

Article

Physician-assisted death should be available to people with MS - No.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1679, doi. 10.1177/1352458517713670

By:

Scolding, Neil

Publication type:

Article

Physician-assisted death should be available to people with MS - YES.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1677, doi. 10.1177/1352458517711775

By:

Wiebe, Kim Louise

Publication type:

Article

Neuromodulation in multiple sclerosis.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1663, doi. 10.1177/1352458517736150

By:

Abboud, Hesham;
Hill, Eddie;
Siddiqui, Junaid;
Serra, Alessandro;
Walter, Benjamin

Publication type:

Article

Fluid biomarkers for disease activity in multiple sclerosis.

Published in:

2017

By:

Zetterberg, Henrik;
Teunissen, Charlotte

Publication type:

Editorial

Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS.

Published in:

Multiple Sclerosis Journal, 2017, v. 23, n. 13, p. 1257, doi. 10.1177/1352458516687402

By:

Capra, Ruggero;
Cordioli, Cinzia;
Rasia, Sarah;
Gallo, Fabio;
Signori, Alessio;
Sormani, Maria Pia

Publication type:

Article

Corrigendum.

Published in:: 2017
Publication type:: Correction Notice

MS Research Australia Progress in MS Research 2017.

Published in:: 2017
Publication type:: Abstract